No video

Understanding the KATHERINE Study: Kadcyla vs. Herceptin After Surgery

  Рет қаралды 5,755

Breastcancer.org

Breastcancer.org

Күн бұрын

Dr. Marisa Weiss, Chief Medical Officer of Breastcancer.org, discusses the results of the KATHERINE study at the 2018 San Antonio Breast Cancer Symposium. The study found that women with early-stage, HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy had better outcomes with Kadcyla compared to Herceptin. Read more about this study here: www.breastcanc....

Пікірлер: 1
@stacimcclain2660
@stacimcclain2660 10 ай бұрын
The volume is very low on this video
HER2-Positive Breast Cancer-Reduce Your Risk of Recurrence | Access Health
20:11
HER2-Positive Breast Cancer-Reduce Your Risk of Recurrence | Access Health
Access Health
Рет қаралды 155 М.
Understanding your treatment: Kadcyla chemotherapy
25:33
Understanding your treatment: Kadcyla chemotherapy
charlottecancer
Рет қаралды 125 М.
WHOA, HUMAN! ARE YOU A FRIDGE-NINJA? SHOW ME THOSE FOOD STORING PAWS! 😺🗡️
00:14
WHOA, HUMAN! ARE YOU A FRIDGE-NINJA? SHOW ME THOSE FOOD STORING PAWS! 😺🗡️
What the Meowk!
Рет қаралды 9 МЛН
Joker can't swim!#joker #shorts
00:46
Joker can't swim!#joker #shorts
Untitled Joker
Рет қаралды 40 МЛН
Мы сделали гигантские сухарики! #большаяеда
00:44
Мы сделали гигантские сухарики! #большаяеда
Кушать Хочу
Рет қаралды 3,8 МЛН
Running With Bigger And Bigger Feastables
00:17
Running With Bigger And Bigger Feastables
MrBeast
Рет қаралды 144 МЛН
Cancer-Related Cognitive Changes: Beyond Chemo Brain
30:21
Cancer-Related Cognitive Changes: Beyond Chemo Brain
VCU Massey
Рет қаралды 950
How Long Do Aromatase Inhibitor Side Effects Last? All You Need to Know
7:15
How Long Do Aromatase Inhibitor Side Effects Last? All You Need to Know
Yerbba – Breast Cancer
Рет қаралды 7 М.
How This 24-Year-Old Finally Discovered She Had Ovarian Cancer | ELLE Out Loud
12:43
How This 24-Year-Old Finally Discovered She Had Ovarian Cancer | ELLE Out Loud
ELLE
Рет қаралды 1,6 МЛН
Adjuvant T-DM1 for HER 2+ Breast Cancer: Critical Data From The KATHERINE Study
5:42
Adjuvant T-DM1 for HER 2+ Breast Cancer: Critical Data From The KATHERINE Study
PracticeUpdate
Рет қаралды 649
The Science and Side Effects of Herceptin and Perjeta, my HER2+breast cancer journey
25:33
The Science and Side Effects of Herceptin and Perjeta, my HER2+breast cancer journey
Yarn Lab
Рет қаралды 6 М.
Sharing my Her2+ Breast Cancer Diagnosis Story at 35 years old
33:34
Sharing my Her2+ Breast Cancer Diagnosis Story at 35 years old
Yarn Lab
Рет қаралды 30 М.
The meaning of residual disease in breast cancer
5:47
The meaning of residual disease in breast cancer
VJOncology
Рет қаралды 3 М.
Patient Perspectives on T-DM1 vs Paclitaxel/Trastuzumab for HER2+ Early Breast Cancer
4:54
Patient Perspectives on T-DM1 vs Paclitaxel/Trastuzumab for HER2+ Early Breast Cancer
PracticeUpdate
Рет қаралды 1,1 М.
How I Found Out my Cancer Came Back | Metastatic Breast Cancer
13:56
How I Found Out my Cancer Came Back | Metastatic Breast Cancer
Nalie
Рет қаралды 206 М.
How Does Alcohol Affect Breast Cancer Risk?
3:10
How Does Alcohol Affect Breast Cancer Risk?
Breastcancer.org
Рет қаралды 1,8 М.
WHOA, HUMAN! ARE YOU A FRIDGE-NINJA? SHOW ME THOSE FOOD STORING PAWS! 😺🗡️
00:14
WHOA, HUMAN! ARE YOU A FRIDGE-NINJA? SHOW ME THOSE FOOD STORING PAWS! 😺🗡️
What the Meowk!
Рет қаралды 9 МЛН